Showing 2021-2030 of 3511 results for "".
How Do You Compare? Financial Benchmarking Survey Measures Aesthetic Market
https://practicaldermatology.com/topics/practice-management/how-do-you-compare-financial-benchmarking-survey-measures-aesthetic-market/23002/Results of an annual benchmarking survey among medical aesthetic, dermatology, and medispa practices across the US.Dermatologic Disparities: Essential Considerations in Patient Care
https://practicaldermatology.com/topics/skin-of-color/dermatologic-disparities-essential-considerations-in-patient-care/22987/A brief review of dermatologic healthcare disparities in the lesbian, gay, bisexual, and transgender (LGBT) community and racial minority groups, including African Americans, Hispanics, and Asian/Pacific Islanders.FAST ASK: Simplifying Challenging Conversations
https://practicaldermatology.com/topics/practice-management/fast-ask-simplifying-challenging-conversations/22982/SCALE Notes
https://practicaldermatology.com/issues/supplements/scale-notes/22088/News and views from Music City SCALEPhysician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20825/Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.Empathy and Transactional Medicine: Improving Patient and Physician Outcomes
https://practicaldermatology.com/topics/skin-cancer-photoprotection/transactional-medicine-improving-patient-and-physician-outcomes/20316/For each individual patient, the patient-physician interaction is unique and requires vulnerability, exposure, and discomfort.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20409/Almirall/Allergan, LEO/Bayer Deals
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-almirall-allergan-leo-bayer-deals/18240/Leo Pharma has agreed to acquire Bayer's global prescription dermatology unit, and Almirall will acquire Allergan's US portfolio of medical dermatology drugs. When it comes to patient engagement, aesthetic practices often have the right mindset, but they may lack the skills or time necessary to exec